Bristol-Myers Squibb Co (NYSE:BMY)

64.68
Delayed Data
As of May 05
 +0.73 / +1.14%
Today’s Change
54.07
Today|||52-Week Range
67.16
+4.27%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$139.4B

Company Description

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers chemically-synthesized drugs or small molecules and products produced from biological processes called biologics. The company was founded in August 1933 and is headquartered in New York, NY.

Contact Information

Bristol Myers Squibb Co.
430 East 29th Street
New York New York 10016
P:(212) 546-4000
Investor Relations:
(609) 252-3396

Employees

Shareholders

Mutual fund holders39.32%
Other institutional36.99%
Individual stakeholders0.33%

Top Executives

Giovanni CaforioChairman & Chief Executive Officer
David V. ElkinsChief Financial Officer & Executive Vice President
Paul von AutenriedChief Information Officer & Executive VP
Rupert J. VesseyExecutive VP-Research & Early Development
Joseph E. EidSenior VP & Head-Global Medical Affairs